Plain-English translation of NCT07328243 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing irreversible electroporation (IRE)—a procedure that uses electrical pulses delivered through ultrasound guidance to destroy cancer cells in lymph nodes in your neck. The study is designed for people whose thyroid cancer has come back in the lymph nodes after they've already had thyroid surgery and cannot have repeat surgery or radioactive iodine treatment. Researchers want to understand how well and how safely this treatment works.
Some people with thyroid cancer develop cancer in their neck lymph nodes after their initial surgery, but surgery or radioactive iodine may not be an option for them. This trial exists to see if the electrical pulse treatment offers a safe and effective option for these patients.
You likely qualify if…
You likely don't qualify if…
You will have a screening visit with imaging and blood tests, then receive the electrical pulse treatment as an outpatient procedure guided by ultrasound. Your pain will be monitored for the first 72 hours using a simple pain scale. You'll have imaging re-assessment at one month; if needed, a second treatment may be offered within 2 weeks. After that, you will return for follow-up visits every 3 months for up to 2 years, with imaging scans at each visit to check how well the treatment worked and whether the cancer has returned.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
China